Venclexta 100 MG tablet UU 120S
Ended Awarded
- Contract number
- SPE2DB25FJZ86
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,456
Award facts
- Contract value 100% obligated
- $19,456.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Venclexta 100 mg tablets (120-count units) with a ceiling value of $19,456.34. This firm fixed-price delivery order, with an ultimate completion date of October 10, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and fulfills the order from its corporate office location. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical procurement support to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company's federal contract portfolio demonstrates extensive capability in supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The DLA Troop Support Medical IDC under which this delivery order falls enables the contractor to supply pharmaceutical products globally to support military healthcare programs. The DLA has indicated plans to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards involving at least three different contractors, reflecting the strategic importance of pharmaceutical supply chain management within the defense medical procurement ecosystem.
Quick answers
Who was awarded contract SPE2DB25FJZ86?
SPE2DB25FJZ86 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 19, 2025.
How much is contract SPE2DB25FJZ86 worth?
The government has obligated $19,456 on SPE2DB25FJZ86.
Is contract SPE2DB25FJZ86 an order under another contract?
Yes. SPE2DB25FJZ86 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJZ86 competed?
The extent of competition for SPE2DB25FJZ86 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award